Status:
COMPLETED
Regional Anesthesia to Reduce Opioid Use Following Functional Endoscopic Sinus Surgery
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Pain Management
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Opioids are prescribed for moderate to severe pain disorders; however, there are contraindications and side effects that are common to all opioids. The investigators hypothesize using regional anesthe...
Detailed Description
Opioid analgesics are prescribed for moderate to severe acute pain; however, there are contraindications, cautions, and side effects that are common with all opioids. Dependence and tolerance are also...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Able to sign informed consent form
- Able to comply with all study procedures and availability for the duration of the study
- Able to speak English
- Diagnosis of chronic rhinosinusitis
- Scheduled to receive functional endoscopic sinus surgery (FESS) at UAB
Exclusion
- Current use of opioid medication
- Known allergic reactions to components of the study intervention
- History of IV drug use or abuse
- History of opioid abuse
- History of chronic pain disorder
- Treatment with another investigational drug or other intervention within 30 days
Key Trial Info
Start Date :
May 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 12 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03757715
Start Date
May 20 2019
End Date
April 12 2021
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233